TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33500115

Group type: EXPERIMENTAL
Intervention: Home management (n=66)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Primary care physician follow-up (n=67)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Home management
Number of subjects: 149
Study: 35552528

Group type: EXPERIMENTAL
Intervention: KarXT (xanomeline-trospium)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170
Study: 34244280

Group type: EXPERIMENTAL
Intervention: Postoperative antibiotic prophylaxis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32466056

Group type: EXPERIMENTAL
Intervention: Simvastatin treatment (80 mg via nasogastric tube)
Number of subjects: 84

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 84
Study: 34157957

Group type: EXPERIMENTAL
Intervention: Recommended dairy diet plus exercise (RDa, n = 24)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Low dairy diet plus exercise (LDa, n = 25)
Number of subjects: 63

Group type: COMPARATOR
Intervention: No-intervention control (n = 14)
Number of subjects: 63
Study: 32891136

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.2 μg·kg‐1 combined with remifentanil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.3 μg·kg‐1 combined with remifentanil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.4 μg·kg‐1 combined with remifentanil
Number of subjects: 0
Study: 34089046

Group type: EXPERIMENTAL
Intervention: Earned Income Tax Credit (4-fold increase)
Number of subjects: 5968

Group type: COMPARATOR
Intervention: Current federal Earned Income Tax Credit
Number of subjects: 5968
Study: 33278614

Group type: EXPERIMENTAL
Intervention: Modular hemiarthroplasty implant
Number of subjects: 958

Group type: COMPARATOR
Intervention: Traditional monoblock implant
Number of subjects: 958

Group type: EXPERIMENTAL
Intervention: Quality of life (EuroQol EQ5D)
Number of subjects: 958

Group type: EXPERIMENTAL
Intervention: Length of stay
Number of subjects: 958
Study: 33137516

Group type: EXPERIMENTAL
Intervention: Benralizumab
Number of subjects: 15
Study: 35935320

Group type: EXPERIMENTAL
Intervention: Ciprofol anesthesia
Number of subjects: 96

Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 96
Study: 35139910

Group type: EXPERIMENTAL
Intervention: Biofeedback-mediated pelvic floor muscle training (PFMT) plus neuromuscular electrical stimulation (NMES)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Conventional pelvic floor muscle training (PFMT)
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Biofeedback-mediated PFMT plus NMES
Number of subjects: 274

Group type: COMPARATOR
Intervention: Conventional PFMT
Number of subjects: 274
Study: 33009228

Group type: EXPERIMENTAL
Intervention: PRC‐063 (100 mg/d)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Immediate‐release methylphenidate (20 mg, 3 times daily)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: PRC‐063 sprinkled on food
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: PRC‐063 under fasted conditions
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: PRC‐063 under high-fat, high-calorie meal conditions
Number of subjects: 3
Study: 35331230

Group type: EXPERIMENTAL
Intervention: Yoga with high dose vitamin D (4000 IU)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Yoga with low dose vitamin D (2000 IU)
Number of subjects: 30

Group type: COMPARATOR
Intervention: High dose vitamin D (4000 IU)
Number of subjects: 30
Study: 33222470

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.4 µg/kg
Number of subjects: 71

Group type: COMPARATOR
Intervention: Fentanyl 4 µg/kg
Number of subjects: 71
Study: 34628979

Group type: EXPERIMENTAL
Intervention: Local vibration
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ShotBlocker
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 32530869

Group type: EXPERIMENTAL
Intervention: Foot reflexology applied for 30 minutes before the procedures
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Foot reflexology
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 56
Study: 33021585

Group type: COMPARATOR
Intervention: Passive recovery (control)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cryotherapy (immersion in water 15° C for 10 minutes)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Vitamins C (1 g) and E (800 UI) supplementation 40 minutes before exercise
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Association of vitamins (C and E) with cryotherapy
Number of subjects: 14
Study: 34889772

Group type: EXPERIMENTAL
Intervention: My Stress Control (MSC) web-based program
Number of subjects: 92

Group type: COMPARATOR
Intervention: Wait-list group (control)
Number of subjects: 92
Study: 32006455

Group type: EXPERIMENTAL
Intervention: Far infrared emitting bioceramics wraps
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo wraps
Number of subjects: 35
Study: 34100742

Group type: EXPERIMENTAL
Intervention: Language intervention protocol combined with auditory verbal therapy (AVT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Auditory verbal therapy (AVT)
Number of subjects: 60
Study: 35779532

Group type: EXPERIMENTAL
Intervention: Intensive home treatment
Number of subjects: 246

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 246
Study: 33448539

Group type: EXPERIMENTAL
Intervention: Symbol Digit Modalities Test (SDMT)
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: Paced Auditory Serial Addition Test (PASAT)
Number of subjects: 889
Study: 34596759

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IP)
Number of subjects: 17

Group type: COMPARATOR
Intervention: SHAM treatment
Number of subjects: 17
Study: 33857800

Group type: EXPERIMENTAL
Intervention: High dose group (n = 10) performed 4320 steps
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low dose group (n = 10) performed 144 steps
Number of subjects: 20
Study: 35554747

Group type: EXPERIMENTAL
Intervention: Amiloride (10mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 32792771

Group type: EXPERIMENTAL
Intervention: Intralesional injection of triamcinolone acetonide (10 mg/mL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intralesional autologous platelet-rich plasma (PRP) injection
Number of subjects: 40
Study: 36176044

Group type: EXPERIMENTAL
Intervention: Padsevonil 50 mg
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Padsevonil 100 mg
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Padsevonil 200 mg
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Padsevonil 400 mg
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Padsevonil 100 mg (EP0092)
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Padsevonil 200 mg (EP0092)
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Padsevonil 400 mg (EP0092)
Number of subjects: 641

Group type: COMPARATOR
Intervention: Placebo (EP0091)
Number of subjects: 641

Group type: COMPARATOR
Intervention: Placebo (EP0092)
Number of subjects: 641
Study: 33477112

Group type: EXPERIMENTAL
Intervention: Treadmill
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Elliptical Trainer
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Stepper
Number of subjects: 18

Group type: COMPARATOR
Intervention: All modalities (Treadmill, Elliptical Trainer, Stepper)
Number of subjects: 18
Study: 32791665

Group type: EXPERIMENTAL
Intervention: Sirolimus 2 mg orally once daily for 16 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sirolimus
Number of subjects: 20
Study: 35891255

Group type: EXPERIMENTAL
Intervention: Double dose (DD) of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine
Number of subjects: 130

Group type: COMPARATOR
Intervention: Normal dose (ND) of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Double dose (DD)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 130
Study: 33487189

Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch-up (ABC) intervention (n = 43)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control intervention (n = 51)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Low-risk parents (n = 79)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: CPS-referred parents who received ABC intervention
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Secure base script knowledge
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: ABC intervention
Number of subjects: 122
Study: 33027799

Group type: EXPERIMENTAL
Intervention: High tertile of net ultrafiltration (NUF) rate (>1.75 mL/kg/h)
Number of subjects: 941

Group type: COMPARATOR
Intervention: Middle tertile of net ultrafiltration (NUF) rate (1.01-1.75 mL/kg/h)
Number of subjects: 941

Group type: EXPERIMENTAL
Intervention: Low tertile of net ultrafiltration (NUF) rate (<1.01 mL/kg/h)
Number of subjects: 941

Group type: EXPERIMENTAL
Intervention: Baseline cardiovascular SOFA score
Number of subjects: 941
Study: 32623361

Group type: EXPERIMENTAL
Intervention: Valgus bracing at maximum tension
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Valgus bracing (all tension levels)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No bracing (control condition)
Number of subjects: 32
Study: 35448970

Group type: EXPERIMENTAL
Intervention: Virtual reality-based vision therapy
Number of subjects: 63

Group type: COMPARATOR
Intervention: Office-based vergence/accommodative therapy
Number of subjects: 63
Study: 34598980

Group type: EXPERIMENTAL
Intervention: Acupuncture (10 sessions, 2 sessions per week)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: TENS (daily home-based for 5 weeks)
Number of subjects: 113
Study: 32589230

Group type: EXPERIMENTAL
Intervention: Apixaban (2.5 mg orally twice daily)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Enoxaparin (40 mg subcutaneously daily)
Number of subjects: 400
Study: 36356410

Group type: EXPERIMENTAL
Intervention: EVE esc (2.5 mg/day week 1; 5 mg/day week 2; 7.5 mg/day week 3; 10 mg/day weeks 4-24)
Number of subjects: 160

Group type: COMPARATOR
Intervention: EVE 10mg (10 mg/day for 24 weeks plus exemestane)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: EVE esc
Number of subjects: 160

Group type: COMPARATOR
Intervention: EVE 10mg
Number of subjects: 160
Study: 34227158

Group type: EXPERIMENTAL
Intervention: Longer child and parental exposure to electronic media
Number of subjects: 1667

Group type: COMPARATOR
Intervention: Children at 18 months
Number of subjects: 1667

Group type: COMPARATOR
Intervention: Children at 24 months
Number of subjects: 1667
Study: 36175977

Group type: EXPERIMENTAL
Intervention: Integrated mental health care and vocational rehabilitation (IBBIS-II)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Standard mental health care and vocational rehabilitation service (Service as Usual - SAU)
Number of subjects: 900
Study: 34669900

Group type: EXPERIMENTAL
Intervention: Traditional teaching associated with simulated teaching
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional teaching
Number of subjects: 60
Study: 32921984

Group type: EXPERIMENTAL
Intervention: QR code video education and traditional information leaflet (Group A)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Traditional information leaflet only (Group B)
Number of subjects: 154
Study: 36035935

Group type: EXPERIMENTAL
Intervention: Original dose of neurohumoral blockades
Number of subjects: 50

Group type: COMPARATOR
Intervention: Halved dose of neurohumoral blockades
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both doses of neurohumoral blockades
Number of subjects: 50
Study: 33427861

Group type: EXPERIMENTAL
Intervention: Family Navigation (FN)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Conventional Care Management (CCM)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Family Navigation (FN) among Hispanic families
Number of subjects: 249

Group type: COMPARATOR
Intervention: Conventional Care Management (CCM) among Hispanic families
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Family Navigation (FN) among non-Hispanic families
Number of subjects: 249

Group type: COMPARATOR
Intervention: Conventional Care Management (CCM) among non-Hispanic families
Number of subjects: 249
Study: 35209984

Group type: EXPERIMENTAL
Intervention: Intermittent iron supplementation
Number of subjects: 147

Group type: COMPARATOR
Intervention: Conventional iron supplementation
Number of subjects: 147
Study: 36038890

Group type: EXPERIMENTAL
Intervention: Titrated ventilation, sedation, and sweep gas flow
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: VV-ECMO
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: PEEP level associated with improved dynamic compliance
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Partial neuromuscular blockade (pNMBA)
Number of subjects: 30
Study: 34197132

Group type: EXPERIMENTAL
Intervention: pABI group
Number of subjects: 76

Group type: COMPARATOR
Intervention: Healthy controls (HCs)
Number of subjects: 76
Study: 36042633

Group type: EXPERIMENTAL
Intervention: Phellinus linteus extract (1000 mg per day for 8 weeks)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo (1000 mg dextrin per day for 8 weeks)
Number of subjects: 98
Study: 34023318

Group type: EXPERIMENTAL
Intervention: Personalized-dose corticosteroid therapy for 5 days
Number of subjects: 248

Group type: COMPARATOR
Intervention: Fixed-dose corticosteroid therapy (40 mg of prednisolone) for 5 days
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Personalized-dose corticosteroid therapy
Number of subjects: 248

Group type: COMPARATOR
Intervention: Fixed-dose corticosteroid therapy
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Personalized-dose corticosteroid therapy (40 mg or less)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Personalized-dose corticosteroid therapy (more than 40 mg)
Number of subjects: 248
Study: 33032560

Group type: EXPERIMENTAL
Intervention: Absorbable skin suture with closure of the subcutaneous fascia (Group 4)
Number of subjects: 849

Group type: COMPARATOR
Intervention: Non-absorbable skin suture with closure of the subcutaneous fascia (Group 3)
Number of subjects: 849

Group type: COMPARATOR
Intervention: Absorbable skin suture without closure of the subcutaneous fascia (Group 2)
Number of subjects: 849

Group type: COMPARATOR
Intervention: Non-absorbable skin suture without closure of the subcutaneous fascia (Group 1)
Number of subjects: 849
Study: 34741631

Group type: EXPERIMENTAL
Intervention: IMAGE1S-assisted TURBT
Number of subjects: 689

Group type: COMPARATOR
Intervention: WL-assisted TURBT
Number of subjects: 689
Study: 34238446

Group type: EXPERIMENTAL
Intervention: Intensive prevention program (IPP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short reinterventions (“Prevention Boosts”)
Number of subjects: 0
Study: 36066508

Group type: EXPERIMENTAL
Intervention: Conditional cash transfer
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Unconditional cash transfer
Number of subjects: 453

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 453
Study: 33103789

Group type: EXPERIMENTAL
Intervention: Pre-transfusion furosemide
Number of subjects: 1356

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1356
Study: 35574948

Group type: EXPERIMENTAL
Intervention: Pressure-controlled reperfusion with delayed stenting (PCRDS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard primary percutaneous coronary intervention with immediate stenting (IS)
Number of subjects: 20
Study: 34176014

Group type: COMPARATOR
Intervention: Dexa‐BEAM (dexamethasone, carmustine, etoposide, cytarabine, melphalan; N = 37)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: MIFAP (mitoxantrone, fludarabine, cytarabine, cisplatin; N = 36)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: MIFAP
Number of subjects: 73

Group type: COMPARATOR
Intervention: Dexa‐BEAM
Number of subjects: 73
Study: 616886766

Group type: EXPERIMENTAL
Intervention: Modified Sanxiang Xiaopi decoction (80 mL through a stomach tube for 14 days)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (enhanced anti-infection and nutrition support without modified Sanxiang Xiaopi decoction)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Modified Sanxiang Xiaopi decoction
Number of subjects: 80
Study: 33917503

Group type: EXPERIMENTAL
Intervention: Combination of Lactoplantibacillus plantarum strains CECT7527, CECT7528, and CECT7529 plus 10 mg of monacolin K
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 35334144

Group type: EXPERIMENTAL
Intervention: Video condition featuring a personal/affective narrative
Number of subjects: 977

Group type: EXPERIMENTAL
Intervention: Essay conditions prompting reflection
Number of subjects: 977

Group type: EXPERIMENTAL
Intervention: Experimental conditions
Number of subjects: 977

Group type: COMPARATOR
Intervention: Control conditions
Number of subjects: 977
Study: 34831986

Group type: EXPERIMENTAL
Intervention: Sit-to-stand training combined with real-time visual feedback (RVF-STS group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Classic sit-to-stand training (C-STS group)
Number of subjects: 30
Study: 32163723

Group type: EXPERIMENTAL
Intervention: Mean absolute glucose (MAG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low blood glucose index
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Index of glycemic control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percentage time in glucose target 70-180 mg/dL
Number of subjects: 0
Study: 35487505

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum LMT1-48 (2×10^10 CFU)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 33632215

Group type: EXPERIMENTAL
Intervention: Digital information tool with VR-technology and standard care (oral and written information)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard care and information (oral and written)
Number of subjects: 160
Study: 35699834

Group type: EXPERIMENTAL
Intervention: sunitinib
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: bevacizumab
Number of subjects: 52
Study: 34636527

Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic exercise training program (30-45 minutes, 50-70% heart rate reserve) on the AlterG treadmill for 12 weeks
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study: 34670021

Group type: EXPERIMENTAL
Intervention: Screening for incidental findings (IFs)
Number of subjects: 1838

Group type: EXPERIMENTAL
Intervention: Screening for blood-borne virus infection
Number of subjects: 1838

Group type: EXPERIMENTAL
Intervention: Screening for elevated alanine transaminase (ALT)
Number of subjects: 1838

Group type: EXPERIMENTAL
Intervention: Assessment of social habits
Number of subjects: 1838
Study: 34293164

Group type: EXPERIMENTAL
Intervention: Large change intervention
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Small change intervention
Number of subjects: 599
Study: 32641090

Group type: EXPERIMENTAL
Intervention: 2-min blind
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: 2 min with guidance
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: 4-min blind
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: 4 min with guidance
Number of subjects: 500
Study: 34741564

Group type: EXPERIMENTAL
Intervention: CLS-TA
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control (rescue therapy)
Number of subjects: 129
Study: 33772134

Group type: EXPERIMENTAL
Intervention: Total Caries Removal (TCR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Selective Caries Removal (SCR)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Two-surface restorations
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Single-surface restorations
Number of subjects: 120
Study: 36156456

Group type: EXPERIMENTAL
Intervention: Virtual visits using phentermine
Number of subjects: 100

Group type: COMPARATOR
Intervention: In-person visits using phentermine
Number of subjects: 100
Study: 34412653

Group type: EXPERIMENTAL
Intervention: Movement‐to‐Music (M2M)
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Standard Exercise Training (SET)
Number of subjects: 327

Group type: COMPARATOR
Intervention: Attention Control (AC)
Number of subjects: 327
Study: 32762725

Group type: EXPERIMENTAL
Intervention: Nutritional status assessment using full MNA (Mini Nutritional Assessment)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Living alone
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Multiple physical disabilities
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Chronic disease
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Financial independency
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Functional ability on ADL (Activities of Daily Living)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Functional ability on IADL (Instrumental Activities of Daily Living)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Normal cognitive status
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: No frailty
Number of subjects: 326
Study: 35032443

Group type: EXPERIMENTAL
Intervention: Daily bathing with 2% chlorhexidine gluconate (CHG) detergent solution
Number of subjects: 1487

Group type: COMPARATOR
Intervention: Daily bathing with pH neutral soap and water
Number of subjects: 1487
Study: 33865308

Group type: EXPERIMENTAL
Intervention: Balance exercises during daily tooth brushing (twice daily for three minutes over eight weeks)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Passive control group (no intervention)
Number of subjects: 51
Study: 36096771

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: High molecular weight hyaluronic acid (HA) injections
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Combination of PRP and HA injections (PRP+HA)
Number of subjects: 105
Study: 35109584

Group type: EXPERIMENTAL
Intervention: Multimodal personalized lifestyle intervention (dietary and physical activity counseling and cognitive training) combined with dietary supplement epigallocatechin gallate (EGCG)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 68
Study: 32873263

Group type: EXPERIMENTAL
Intervention: BPB (100 g)
Number of subjects: 70

Group type: COMPARATOR
Intervention: PB (100 g)
Number of subjects: 70